Loading...
Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis
Objectives: To examine whether the increased risk of cardiovascular events with rofecoxib represents a class effect of cyclooxygenase-2 (COX-2) specific inhibitors. Design: Systematic review and meta-analysis of randomized double-blind clinical trials of celecoxib of at least 6 weeks' duration...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Royal Society of Medicine
2006
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1383759/ https://ncbi.nlm.nih.gov/pubmed/16508052 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|